288
Views
23
CrossRef citations to date
0
Altmetric
Research Article

The effects of cinnarizine versus sodium valproate in migraine prophylaxis

, , , &
Pages 487-493 | Received 30 Jul 2012, Accepted 08 Jan 2013, Published online: 11 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mansoureh Togha, Fahime Martami, Mohammad Abdollahi, Mohammad Mozafari, Hamed Cheraghali, Pegah Rafiee & Maryam Shafaei. (2020) Cinnarizine as an alternative recommendation for migraine prophylaxis: a narrative review. Expert Review of Neurotherapeutics 20:9, pages 943-951.
Read now
Lorenza Chiossi, Andrea Negro, Matilde Capi, Luana Lionetto & Paolo Martelletti. (2014) Sodium channel antagonists for the treatment of migraine. Expert Opinion on Pharmacotherapy 15:12, pages 1697-1706.
Read now

Articles from other publishers (21)

Alessandro Ferretti, Mattia Gatto, Margherita Velardi, Giovanni Di Nardo, Thomas Foiadelli, Gianluca Terrin, Manuela Cecili, Umberto Raucci, Massimiliano Valeriani & Pasquale Parisi. (2023) Migraine, Allergy, and Histamine: Is There a Link?. Journal of Clinical Medicine 12:10, pages 3566.
Crossref
Christian Lampl, Antoinette MaassenVanDenBrink, Christina I. Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Margarita Sanchez-del-Rio, Uwe Reuter, Derya Uluduz, Jan Versijpt, Dena Zeraatkar & Simona Sacco. (2023) The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. The Journal of Headache and Pain 24:1.
Crossref
Prathamesh Gawde, Harsh Shah, Harsh Patel, Koppineedi S Bharathi, Neil Patel, Yashendra Sethi & Nirja Kaka. (2023) Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management Armamentarium. Cureus.
Crossref
Mohammad Shafie'ei, Mohsen Farjoud Kouhanjani, Zahra Akbari, Nastaran Sarvipour, Dorsa Shekouh, Mohammadhasan Gholampour, Pooneh Memar Ardestani & Hamid Nemati. (2022) Application of cinnarizine in migraine prevention: A systematic review and meta‐analysis. Pain Practice 22:8, pages 733-745.
Crossref
Mohaddeseh Hedayat, Surena Nazarbaghi, Mohammad Heidari & Hamdollah Sharifi. (2022) Venlafaxine can reduce the migraine attacks as well as amitriptyline: A noninferiority randomized trial. Clinical Neurology and Neurosurgery 214, pages 107151.
Crossref
Samira Khani, Seyed Amir Hejazi, Mehdi Yaghoubi & Ehsan Sharifipour. (2021) Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial. The Journal of Headache and Pain 22:1.
Crossref
Chen qi Zhang, Bao ming He, Mei ling Hu & Hong bin Sun. (2020) Risk of Valproic Acid-Related Tremor: A Systematic Review and Meta-Analysis. Frontiers in Neurology 11.
Crossref
Man Amanat, Mansoureh Togha, Elmira Agah, Mahtab Ramezani, Ali Reza Tavasoli, Reza Azizi Malamiri, Fariba Fashandaky, Morteza Heidari, Mona Salehi, Hamid Eshaghi & Mahmoud Reza Ashrafi. (2019) Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial. Cephalalgia 40:7, pages 665-674.
Crossref
Jacob Worm, Katrine Falkenberg & Jes Olesen. (2019) Histamine and migraine revisited: mechanisms and possible drug targets. The Journal of Headache and Pain 20:1.
Crossref
Xueping Wang, Haijiao Wang, Da Xu, Lina Zhu & Ling Liu. (2019) Risk of valproic acid-related alopecia: A systematic review and meta-analysis. Seizure 69, pages 61-69.
Crossref
N. V. Latysheva, E. G. Filatova, D. V. Osipova & A. B. Danilov. (2019) Cognitive functions in patients with episodic and chronic migraine. Medical alphabet 1:2, pages 15-18.
Crossref
GaneshN Dakhale, VikasSohanlal Sharma, ManishN Thakre & Mrunalini Kalikar. (2019) Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study. Indian Journal of Pharmacology 51:4, pages 255.
Crossref
Anne Luise Vollesen, Silvia Benemei, Francesca Cortese, Alejandro Labastida-Ramírez, Francesca Marchese, Lanfranco Pellesi, Michele Romoli, Messoud Ashina & Christian Lampl. (2018) Migraine and cluster headache – the common link. The Journal of Headache and Pain 19:1.
Crossref
Peer Tfelt-Hansen, Janus Kaufmann Lindqvist & Thien Phu Do. (2018) Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010–2015 on migraine drug treatments. Cephalalgia 38:12, pages 1885-1895.
Crossref
Hsiangkuo Yuan & Stephen D. Silberstein. (2017) Histamine and Migraine. Headache: The Journal of Head and Face Pain 58:1, pages 184-193.
Crossref
Anna Ambrosini & Jean Schoenen. 2016. Pharmacological Management of Headaches. Pharmacological Management of Headaches 63 79 .
Rubesh Gooriah, Randa Nimeri & Fayyaz Ahmed. (2015) Evidence-Based Treatments for Adults with Migraine. Pain Research and Treatment 2015, pages 1-13.
Crossref
Jeffrey L. Jackson, Elizabeth Cogbill, Rafael Santana-Davila, Christina Eldredge, William Collier, Andrew Gradall, Neha Sehgal & Jessica Kuester. (2015) A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLOS ONE 10:7, pages e0130733.
Crossref
Dawn C. Buse, Daniel Serrano, Michael L. Reed, Shashi H. Kori, Cedric M. Cunanan, Aubrey Manack Adams & Richard B. Lipton. (2015) Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain 55:6, pages 825-839.
Crossref
Mahmoud Reza Ashrafi, Soodeh Salehi, Reza Azizi Malamiri, Morteza Heidari, Seyed Ahmad Hosseini, Mahboubeh Samiei, Ali Reza Tavasoli & Mansoureh Togha. (2014) Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial. Pediatric Neurology 51:4, pages 503-508.
Crossref
Daniel Serrano, Dawn C. Buse, Shashi H. Kori, Sypridon Papapetropoulos, Cedric M. Cunanan, Aubrey N. Manack, Michael L. Reed & Richard B. Lipton. (2013) Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans. Headache: The Journal of Head and Face Pain, pages n/a-n/a.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.